Literature DB >> 15988914

ABT-751 (Abbott).

Carlos Maria Galmarini1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988914

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


× No keyword cloud information.
  5 in total

Review 1.  Neuroblastoma.

Authors:  Andrew M Davidoff
Journal:  Semin Pediatr Surg       Date:  2012-02       Impact factor: 2.754

2.  A phase I trial and in vitro studies combining ABT-751 with carboplatin in previously treated non-small cell lung cancer patients.

Authors:  Tian Ma; Alexander D Fuld; James R Rigas; Anne E Hagey; Gary B Gordon; Ethan Dmitrovsky; Konstantin H Dragnev
Journal:  Chemotherapy       Date:  2012-11-12       Impact factor: 2.544

3.  Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.

Authors:  Charles M Rudin; Ann Mauer; Martin Smakal; Rosalyn Juergens; Stanislav Spelda; Michael Wertheim; Andrew Coates; Evelyn McKeegan; Peter Ansell; Xiangdong Zhou; Jane Qian; Rajendra Pradhan; Barry Dowell; Andrew Krivoshik; Gary Gordon
Journal:  J Clin Oncol       Date:  2011-02-07       Impact factor: 44.544

Review 4.  Treatment of acute lymphoblastic leukaemia : a new era.

Authors:  Effrosyni Apostolidou; Ronan Swords; Yesid Alvarado; Francis J Giles
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).

Authors:  Elizabeth Fox; Yael P Mosse'; Holly M Meany; James G Gurney; Geetika Khanna; Hollie A Jackson; Gary Gordon; Suzanne Shusterman; Julie R Park; Susan L Cohn; Peter C Adamson; Wendy B London; John M Maris; Frank M Balis
Journal:  Pediatr Blood Cancer       Date:  2013-12-18       Impact factor: 3.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.